SENTI Trademark

Trademark Overview

On Thursday, February 8, 2018, a trademark application was filed for SENTI with the United States Patent and Trademark Office. The USPTO has given the SENTI trademark a serial number of 87790017. The federal status of this trademark filing is REGISTERED as of Tuesday, October 26, 2021. This trademark is owned by Senti Biosciences, Inc.. The SENTI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services
senti

General Information

Serial Number87790017
Word MarkSENTI
Filing DateThursday, February 8, 2018
Status700 - REGISTERED
Status DateTuesday, October 26, 2021
Registration Number6540110
Registration DateTuesday, October 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements

Goods and ServicesPharmaceutical research and development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 16, 2018
Primary Code042
First Use Anywhere DateFriday, April 9, 2021
First Use In Commerce DateFriday, April 9, 2021

Trademark Owner History

Party NameSenti Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSenti Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSenti Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, October 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 21, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 20, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 14, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, August 23, 2021USE AMENDMENT FILED
Monday, August 23, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, February 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 5, 2021EXTENSION 5 GRANTED
Thursday, January 21, 2021EXTENSION 5 FILED
Friday, February 5, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 21, 2021TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020EXTENSION 4 GRANTED
Monday, August 10, 2020EXTENSION 4 FILED
Monday, August 10, 2020TEAS EXTENSION RECEIVED
Friday, January 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 22, 2020EXTENSION 3 GRANTED
Wednesday, January 22, 2020EXTENSION 3 FILED
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Saturday, August 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2019EXTENSION 2 GRANTED
Thursday, August 8, 2019EXTENSION 2 FILED
Thursday, August 8, 2019TEAS EXTENSION RECEIVED
Wednesday, August 7, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 7, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019EXTENSION 1 GRANTED
Friday, February 15, 2019EXTENSION 1 FILED
Friday, February 15, 2019TEAS EXTENSION RECEIVED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 23, 2018ASSIGNED TO EXAMINER
Friday, February 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 12, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

senti services development research pharmaceutical